Literature DB >> 3345066

Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect.

T D Bird1, T H Lampe, E J Nemens, G W Miner, S M Sumi, G D Schellenberg.   

Abstract

Five families are described in which autopsy-confirmed presenile Alzheimer's disease (AD) has occurred in men and women over multiple generations consistent with autosomal dominant inheritance. All 5 families are descendants of a group of immigrants known as the Volga Germans who came to the United States between 1870 and 1920. Their ancestors moved from Germany to the southern Volga region of Russia in the 1760s. All 5 American families are descendants of persons originally living in two small adjacent Volga German villages and share several surnames known to have been present in the census records of those villages. Although a single affected common ancestor cannot be identified, it is likely that the AD in these families represents an autosomal dominant gene inherited from one ancestor (the founder effect). This information is of importance in the genetic study of AD in these families because it greatly increases the probability of genetic homogeneity. There are more than 300,000 American descendants of the Volga Germans, and the prevalence of AD has never been studied in this population.

Entities:  

Mesh:

Year:  1988        PMID: 3345066     DOI: 10.1002/ana.410230106

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  33 in total

1.  The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease.

Authors:  Chang-En Yu; Elizabeth Marchani; Georg Nikisch; Ulrich Müller; Dagmar Nolte; Andreas Hertel; Ellen M Wijsman; Thomas D Bird
Journal:  Arch Neurol       Date:  2010-05

2.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

3.  The genetics of Alzheimer disease--a teasing problem.

Authors:  J L Haines
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

4.  Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.

Authors:  Elizabeth E Marchani; Thomas D Bird; Ellen J Steinbart; Elisabeth Rosenthal; Chang-En Yu; Gerard D Schellenberg; Ellen M Wijsman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

Review 5.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

6.  Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families.

Authors:  Petra Yescas; Adriana Huertas-Vazquez; María Teresa Villarreal-Molina; Astrid Rasmussen; María Teresa Tusié-Luna; Marisol López; Samuel Canizales-Quinteros; María Elisa Alonso
Journal:  Neurogenetics       Date:  2006-04-21       Impact factor: 2.660

7.  Clinico-genealogical study of Alzheimer's disease.

Authors:  N I Voskresenskaya
Journal:  Neurosci Behav Physiol       Date:  1991 Sep-Oct

8.  Genome screens using linkage disequilibrium tests: optimal marker characteristics and feasibility.

Authors:  N H Chapman; E M Wijsman
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

Review 9.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

10.  Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.

Authors:  James B Leverenz; Mark A Fishel; Elaine R Peskind; Thomas J Montine; David Nochlin; Ellen Steinbart; Murray A Raskind; Gerard D Schellenberg; Thomas D Bird; Debby Tsuang
Journal:  Arch Neurol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.